VF
SQZ

Virtu Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

Virtu Financial’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,075
Closed -$10K – 2344
2023
Q1 		$10K Buy
+17,075
New +$12.6K ﹤0.01% 1350
2022
Q1 		– Sell
-12,572
Closed -$112K – 2305
2021
Q4 		$112K Buy
+12,572
New +$154K 0.01% 1084

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's SQZ Position: Q2 2023 in Review

Virtu Financial sold out of SQZ Biotechnologies Company (SQZ) in Q2 2023, closing a stake of 17,075 shares — an estimated $10K sold.

Virtu Financial first reported a position in SQZ in Q4 2021 and held it in 2 quarters. The position peaked at $112K in Q4 2021. 31 funds tracked by Wall St. Rank hold SQZ as of Q2 2023.

  • Virtu Financial reported no remaining SQZ Biotechnologies Company position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 17,075 SQZ Biotechnologies Company shares in Q2 2023, an estimated $10K.
  • Virtu Financial first reported a position in SQZ Biotechnologies Company in Q4 2021 and held it in 2 quarters.
  • Virtu Financial's SQZ Biotechnologies Company position peaked at $112K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.